www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No.4 The antimicrobial peptide pardaxin exerts potent anti-tumor activity against canine perianal gland adenoma Chieh-Yu Pan1, Chao-Nan Lin2, Ming-Tang Chiou2, Chao Yuan Yu3, Jyh-Yih Chen4 and Chi-Hsien Chien2 1 Department and Graduate Institute of Aquaculture, National Kaohsiung Marine University, Nanzih Dist., Kaohsiung, Taiwan 2 Graduate Institute and Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology, Neipu, Pingtung, Taiwan 3 Genomics BioSci & Tech Co., Ltd., Xizhi Dist., New Taipei, Taiwan 4 Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Ilan, Taiwan Correspondence to: Chi-Hsien Chien, email:
[email protected] Correspondence to: Jyh-Yih Chen, email:
[email protected] Keywords: antimicrobial peptide, pardaxin, cancer treatment, perianal gland adenoma, canine, intratumoral treatment Received: October 25, 2014 Accepted: December 09, 2014 Published: December 10, 2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Pardaxin is an antimicrobial peptide of 33 amino acids, originally isolated from marine fish. We previously demonstrated that pardaxin has anti-tumor activity against murine fibrosarcoma, both in vitro and in vivo. In this study, we examined the anti- tumor activity, toxicity profile, and maximally-tolerated dose of pardaxin treatment in dogs with different types of refractory tumor. Local injection of pardaxin resulted in a significant reduction of perianal gland adenoma growth between 28 and 38 days post-treatment.